Shares of CRH Medical Corp (NYSEAMERICAN:CRHM) have received an average rating of “Buy” from the ten analysts that are covering the firm, MarketBeat reports. One investment analyst has rated the stock with a sell rating, three have issued a hold rating and six have issued a buy rating on the company. The average twelve-month price objective among analysts that have issued a report on the stock in the last year is $7.50.

Several analysts have commented on the company. Zacks Investment Research downgraded CRH Medical from a “hold” rating to a “sell” rating in a research note on Tuesday, November 14th. Morgan Stanley upgraded CRH Medical from an “equal weight” rating to an “overweight” rating in a research note on Friday, November 17th.

Shares of CRH Medical (NYSEAMERICAN CRHM) opened at $2.75 on Friday. The firm has a market capitalization of $196.44, a P/E ratio of 39.29 and a beta of 1.32. CRH Medical has a 52 week low of $1.46 and a 52 week high of $9.25.

Hedge funds and other institutional investors have recently added to or reduced their stakes in the company. Vanguard Group Inc. bought a new position in shares of CRH Medical during the 2nd quarter valued at $150,000. Bank of Montreal Can lifted its holdings in shares of CRH Medical by 128.4% during the 2nd quarter. Bank of Montreal Can now owns 28,700 shares of the company’s stock valued at $164,000 after buying an additional 16,135 shares during the period. Advisor Group Inc. lifted its holdings in shares of CRH Medical by 35.0% during the 2nd quarter. Advisor Group Inc. now owns 36,177 shares of the company’s stock valued at $206,000 after buying an additional 9,389 shares during the period. PDT Partners LLC lifted its holdings in shares of CRH Medical by 176.4% during the 2nd quarter. PDT Partners LLC now owns 50,162 shares of the company’s stock valued at $285,000 after buying an additional 32,013 shares during the period. Finally, TD Asset Management Inc. lifted its holdings in shares of CRH Medical by 65.3% during the 3rd quarter. TD Asset Management Inc. now owns 111,054 shares of the company’s stock valued at $289,000 after buying an additional 43,851 shares during the period.

TRADEMARK VIOLATION NOTICE: This story was originally posted by American Banking News and is the property of of American Banking News. If you are reading this story on another publication, it was copied illegally and republished in violation of U.S. and international copyright laws. The legal version of this story can be viewed at https://www.americanbankingnews.com/2018/01/05/crh-medical-corp-crhm-receives-consensus-rating-of-buy-from-brokerages.html.

About CRH Medical

CRH Medical Corporation is a Canada-based healthcare products and services company. The Company focused on providing physicians with services and products for the treatment of gastrointestinal diseases. The Company also provides anesthesiology services to gastroenterologists in the United States through its subsidiaries.

Analyst Recommendations for CRH Medical (NYSEAMERICAN:CRHM)

Receive News & Ratings for CRH Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CRH Medical and related companies with MarketBeat.com's FREE daily email newsletter.